KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Current Assets (2016 - 2026)

Amgen has reported Current Assets over the past 18 years, most recently at $31.5 billion for Q1 2026.

  • For Q1 2026, Current Assets rose 16.88% year-over-year to $31.5 billion; the TTM value through Mar 2026 reached $31.5 billion, up 16.88%, while the annual FY2025 figure was $29.1 billion, 0.09% changed from the prior year.
  • Current Assets for Q1 2026 was $31.5 billion at Amgen, up from $29.1 billion in the prior quarter.
  • Over five years, Current Assets peaked at $48.5 billion in Q3 2023 and troughed at $18.5 billion in Q1 2022.
  • A 5-year average of $29.9 billion and a median of $27.9 billion in 2025 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: surged 145.21% in 2023 and later plummeted 44.79% in 2024.
  • Year by year, Current Assets stood at $22.2 billion in 2022, then surged by 36.72% to $30.3 billion in 2023, then decreased by 4.29% to $29.0 billion in 2024, then grew by 0.09% to $29.1 billion in 2025, then grew by 8.32% to $31.5 billion in 2026.
  • Business Quant data shows Current Assets for AMGN at $31.5 billion in Q1 2026, $29.1 billion in Q4 2025, and $27.9 billion in Q3 2025.